Decentralized Science (Desci) platform bio protocol secured backing from investors including Maelstrom fund and Animoca brands to expand artificial intelligence-native biotech research framework.
Bio Protocol announced This Wednesday raised $ 6.9 million in funding, reflecting the growing interest in the decentralized approach to exploring drugs that included AI, blockchain and community relationships.
Maelstrom founder Arthur Hayes described the bio protocol as a potential “category that refers to the launch” for scientific research. “If it works, it’s not just a launchpad-it’s the birth of an AI-Native research market,” he said.
Hayes also featured how it opens the research opportunities found by attractive communities, not just what are academics.
Cointelegraph reached Maelstrom and Animoca for more information, but did not receive a response by publishing.
Accelerating science using AI and Crypto
Desci is a movement that Uses blockchain technologyCrypto incentives and decentralized management to change how science research is conducted, funded and shared.
The Bio Protocol said it accelerated science by integrating crypto and AI. Its approach forces the drug detection pipeline using blockchain -based funding and coordination.
Instead of waiting for years for traditional grants awarded or partnerships with Pharma formed, researchers can use decentralized AI agents, called “bioagents” that form hypotheses, connect to onchain and channel wallets.
Each step of the process is recorded on the onchain, ensuring that the contributors will be credited and maintained an unchanged record of research development.
The protocol also uses crypto-native incentives to maintain a faster research transfer. It uses tokenized intellectual property, staking systems and rewards of loyalty to align investors, researchers and community members around the shared outcomes.
Related: ‘Science Needs an update’: How Desci can fix Junk Science and heal bald
Responding to academic research efficiency
Simon Dedic, the founder of Moonrock Capital, one of Bio Protocol investors, Says That Desci’s early possessions may be “sometimes a meme.” However, he said the bio protocol could play a key role in organizing the academic science system.
“From academic science to myself, I know right how the system is damaged, with massive incorrect incentive incentives with deadly consequences throughout
The company has been positioned at its work as part of a larger Desci movement aimed at reducing hopes of universities, government grants and pharmaceutical companies, while making research more accessible to communities and independent scientists.
https://www.youtube.com/watch?v=oqemr3g8Dai
Magazine: Meet Ethereum and Polkadot co-founder who is out of time magazine
